drugset / Trial / NCT04867941
A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study will evaluate the influence of hepatic insufficiency on the PK of ACP-196.
Timeline
- Start
- 2014-10-21
- Primary completion
- 2015-02-02
- Completion
- 2015-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acalabrutinib | Small molecule | 50 mg | Oral |